UCB Partners With Cradle to Apply AI Across Antibody Discovery and Engineering
UCB will use Cradle’s AI-driven protein design platform in selected discovery projects, from hit generation through preclinical readiness, expanding its digital antibody engineering program. “Adding Cradle’s end-to-end platform across our discovery pipeline allows us to apply computational approaches in a…